LOSELABbuyer room · privateManage buyer room
Normalized manufacturer cash-pay (self-pay) GLP-1 price index: a monthly time series of Wegovy, Zepbound and Ozempic maintenance-dose self-pay prices expressed as an index (base 100 = Aug 2025, reading 76.6 in Sep 2026, i.e. -23%), underpinned by a price-change event ledger where every change carries effective date, drug, self-pay price, dose range and conditionality (e.g. refill within 45 days) plus a link to the manufacturer announcement that caused it — alongside per-drug cash-price pages, an overpayment checker keyed to dose/pharmacy/ZIP, and a provider legal-risk tracker.
Get notified as soon as Loselab publishes. Until then, discover alternatives today with a 7-day trial.